Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

NCT06101290 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06101290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06101290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Recruiting
Start date
December 5, 2023
Completion date
January 15, 2035
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligoprogressive, prostate cancer, renal cell carcinoma, urothelial carcinoma